Recently, against the backdrop of a significant correction in the global stock market and increased volatility in the A-share market, foreign-funded institutions have been intensively issuing opinions, clearly optimistic about the performance of the Chinese stock market in the second half of the year. Citi upgraded China's stock rating to “overallocated” and viewed the Chinese market as the preferred target for capital rotation in emerging markets; Standard Chartered also maintained its overallocation position on the Chinese stock market. What is behind the unanimous optimism of foreign-funded institutions is the resilience shown by China's macroeconomy in the first half of the year, as well as the appeal that continues to unleash in innovative fields such as artificial intelligence and biotechnology.

Recently, against the backdrop of a significant correction in the global stock market and increased volatility in the A-share market, foreign-funded institutions have been intensively issuing opinions, clearly optimistic about the performance of the Chinese stock market in the second half of the year. Citi upgraded China's stock rating to “overallocated” and viewed the Chinese market as the preferred target for capital rotation in emerging markets; Standard Chartered also maintained its overallocation position on the Chinese stock market. What is behind the unanimous optimism of foreign-funded institutions is the resilience shown by China's macroeconomy in the first half of the year, as well as the appeal that continues to unleash in innovative fields such as artificial intelligence and biotechnology.